ImmuneOncia Therapeutics, Inc. (KOSDAQ:424870)
South Korea · Delayed Price · Currency is KRW 6,300.00
+340.00 (5.70%)
Last updated: Oct 10, 2025, 2:02 PM KST
ImmuneOncia Therapeutics Revenue
ImmuneOncia Therapeutics had revenue of 59.44M KRW in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to 765.75M. In the year 2024, ImmuneOncia Therapeutics had annual revenue of 654.54M with 495.04% growth.
Revenue (ttm)
765.75M
Revenue Growth
+495.04%
P/S Ratio
608.04
Revenue / Employee
n/a
Employees
n/a
Market Cap
465.61B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 654.54M | 544.54M | 495.04% |
| Dec 31, 2023 | 110.00M | -7.62B | -98.58% |
| Dec 31, 2022 | 7.73B | 7.70B | 21,413.30% |
| Dec 31, 2021 | 35.95M | 33.45M | 1,337.90% |
| Dec 31, 2020 | 2.50M | 1.00M | 66.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Electronics | 308.59T |
| SK hynix | 77.21T |
| LG Energy Solution | 25.16T |
| Samsung Biologics | 5,031.69B |
| Hanwha Aerospace | 19.25T |
| Hyundai Motor Company | 182.25T |
| HD Hyundai Heavy Industries | 15.58T |
| KB Financial Group | 14.92T |